Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

par Yunhai Li, Lei Xing, Fan Li, Hong Liu, Lu Gan, Dejuan Yang, Mengxue Wang, Xuedong Yin, Hongyuan Li, Guosheng Ren, Guosheng Ren
Publié 2021

AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer

par Long Wang, Long Wang, Xue Zhang, Mengxue Wang, Mengxue Wang, Yunhai Li, Jiali Xu, Jiali Xu, Jiaying Wei, Hongzhong Li, Guosheng Ren, Guosheng Ren, Xuedong Yin
Publié 2021

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation

par Kang Wang, Zhuyue Li, Xingxing Chen, Jianjun Zhang, Yongfu Xiong, Guochao Zhong, Yang Shi, Qing Li, Xiang Zhang, Hongyuan Li, Tingxiu Xiang, Theodoros Foukakis, Tomas Radivoyevitch, Guosheng Ren
Publié 2021